M protein gene (emm type) analysis of group A Streptococcus isolates recovered during an acute glomerulonephritis

David J Speers1, Avram Levy2, Adanech Gichamo3

  • 1Department of Microbiology, PathWest Laboratory Medicine WA, Queen Elizabeth II Medical Centre, Hospital Avenue, Nedlands, Australia; School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia.

Pathology
|October 29, 2017
PubMed

Insights

Certain M protein types of group A Streptococcus (GAS) cause acute post-streptococcal glomerulonephritis (APSGN). Analysis of GAS strains in Western Australia during an APSGN outbreak revealed high emm type diversity, with no single predominant type identified.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Immunology

Background:

  • Certain M protein types of group A Streptococcus (GAS) are linked to acute post-streptococcal glomerulonephritis (APSGN).
  • APSGN outbreaks are common in tropical areas, with diverse emm types implicated.
  • Understanding circulating GAS strains is crucial for managing APSGN outbreaks.

Purpose of the Study:

  • To analyze emm types and clusters of GAS isolates from Western Australia during an APSGN outbreak.
  • To determine if a predominant emm type or cluster correlated with APSGN activity in the region.
  • To assess the potential coverage of a new 30-valent GAS M-protein vaccine.

Main Methods:

  • Collection and emm typing of GAS isolates from Western Australia.
  • Analysis of emm types and clusters in relation to APSGN activity.
  • Calculation of potential vaccine coverage based on identified emm types.

Main Results:

  • While emm types 49, 75, and 108 (clusters E3, E6, D4) were more prevalent, no single predominant emm type or cluster was identified during the APSGN outbreak.
  • The findings align with observations of high GAS strain diversity during APSGN outbreaks globally.
  • The analyzed GAS strains indicated a potential vaccine coverage of 70% for a new 30-valent M-protein vaccine.

Conclusions:

  • GAS strain diversity, rather than a single predominant type, characterized the APSGN outbreak in the tropical northern Kimberley region of WA.
  • Effective management and prevention strategies for APSGN may need to account for this genetic diversity.
  • A new 30-valent M-protein vaccine shows promising coverage against the circulating GAS strains.